Premier, Inc. - PINC STOCK NEWS

MedSource Labs has secured a group purchasing agreement for Peripheral Intravenous Catheters (PIVC) Solutions with Premier's AscenDrive™ program. This partnership enables Premier members to access pre-negotiated pricing and terms for ClearSafe® and TrueSafe® products. The AscenDrive™ program aims to enhance purchasing efficiency and standardization among over 4,400 Premier member hospitals. The PIVC market in the U.S. is estimated to exceed $5 billion annually, with a significant percentage of acute care patients requiring peripheral IV catheters. This agreement positions MedSource Labs as a key player in improving safety and quality in this essential healthcare segment.

Premier Inc. (NASDAQ: PINC) has acquired the 100 Top Hospitals program from Merative, enhancing its PINC AI™ analytics and consulting services. This integration aims to recognize high-performing hospitals for quality and service, thereby expanding PINC AI™'s market reach. The program, which originated in 1993, will provide scorecards based on nationally recognized metrics, helping healthcare leaders improve performance and patient outcomes. Premier expects this acquisition to strengthen its brand and cement its position as a leader in healthcare quality improvement.

PINC AI™, a technology platform of Premier, has received the 2023 Best in KLAS designation for Value-Based Care Consulting, recognized for its effectiveness in supporting healthcare providers in value-based care models. Previously awarded in 2022, 2016, and 2017, this accolade underscores the impact of PINC AI™ in enhancing healthcare quality while collaborating with hundreds of hospitals and health systems. The award results from extensive evaluations by KLAS Research, highlighting leading healthcare IT solutions. Premier's commitment to improving health outcomes through data analytics and consulting services remains central to its mission.

Premier, Inc. (NASDAQ: PINC) has reported financial results for Q2 FY 2023, announcing a cost-savings plan while revising its fiscal-year guidance. The company experienced a 5% decline in net revenue year-over-year, totaling $359.6 million. Notably, the Supply Chain Services segment faced a 13% drop in total revenue, primarily due to a 40% decline in product sales. Despite the challenging environment, Premier's Performance Services grew by 15%. The planned workforce reduction of nearly 4% aims to save $18 million to $20 million in FY 2023. Adjusted earnings per share decreased by 1% to $0.72. Premier remains focused on long-term growth despite current challenges.

Ritedose, a South Carolina-based 503B outsourcing facility, has secured a group purchasing agreement with Premier Inc. (PINC), effective January 1, 2023. This agreement allows Premier members access to pre-negotiated pricing and terms for Ritedose's full range of compounded medications. Ritedose provides ready-to-use, single-dose syringe products to various healthcare organizations. Their CEO Jody Chastain highlighted their capability to meet outsourcing needs without disruptions in patient care. Premier, which collaborates with over 4,400 U.S. hospitals, aims to enhance healthcare outcomes and lower costs through integrated services.

Premier, Inc. (NASDAQ: PINC) announced a cash dividend of $0.21 per share on its Class A common stock. The dividend will be paid on March 15, 2023, to stockholders of record as of the close of business on March 1, 2023. This reflects the company's commitment to returning value to its shareholders while supporting its role as a leader in healthcare improvement.

Premier, Inc. (NASDAQ: PINC) will release its fiscal 2023 second-quarter financial results on February 7 at 6:30 a.m. EST. A conference call to discuss these results will follow at 8:00 a.m. EST. Interested participants can access the call via a toll-free domestic number: (833) 953-2438, or internationally at (412) 317-5767. The event will be available for replay for one year on the company’s Investor Relations website. Premier collaborates with over 4,400 U.S. hospitals and aims to improve healthcare outcomes.

Premier Inc. (NASDAQ: PINC), a technology-driven healthcare improvement company, will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. The presentation is scheduled for 11:15 a.m. PST (2:15 p.m. EST) and will be followed by a Q&A session. A live audio webcast and a replay will be available on their website. Premier connects over 4,400 U.S. hospitals and 250,000 providers to enhance healthcare delivery through data, analytics, and consulting services.

Quest Diagnostics (DGX) has secured a group purchasing agreement with Premier Inc. (PINC) for its laboratory stewardship solutions. This collaboration enables Premier members to access Quest's Lab Stewardship Enterprise at special pricing, facilitating improved healthcare delivery. The platform offers data analytics for healthcare organizations, tracking trends and identifying cost-saving opportunities. Quest aims to enhance care quality and operational efficiency as health systems face post-pandemic challenges. This agreement marks a significant enhancement in accessibility for Quest's innovative healthcare solutions.